Advertisement
Collaboration › Details
Merus–Credit Suisse: investor conference, 201609 supply service Merus presents at Credit Suisse Antibody Day 2016 in New York
Period | 2016-09-07 | |
Region | New York, NY | |
Country | United States (USA) | |
Partner, 1st | Merus N.V. (Nasdaq: MRUS) | |
Group | Merus (Group) | |
Partner, 2nd | Credit Suisse (Group) | |
Today | UBS (Group) | |
Group | UBS (Group) | |
Product | Credit Suisse Antibody Day 2016 New York | |
Product 2 | Biclonics® antibody | |
Person | Logtenberg, Ton (Forbion 202203– Venture Partner formerly Merus Founder + CEO + U-BiSys Founder + CEO) | |
Person 2 | Minarovich, Kimberly (Argot Partners 201608) | |
Record changed: 2017-03-05 |
Advertisement
More documents for Merus (Group)
- [1] V-Bio Ventures. (3/31/22). "Press Release: V-Bio Ventures Raises EUR 110 Million for its Second Fund and Expands Team". Ghent....
- [2] Merus N.V.. (1/21/21). "Press Release: Merus Announces Pricing of Public Offering of Common Shares". Utrecht & Cambridge, MA....
- [3] Merus N.V.. (1/19/21). "Press Release: Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies". Indianapolis, IN & Utrecht....
- [4] Merus N.V.. (1/19/21). "Press Release: Merus N.V. Announces Proposed Public Offering of Common Shares". Utrecht & Cambridge, MA....
- [5] Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA....
- [6] ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin....
- [7] ProBioGen AG. (5/24/18). "Press Release: ProBioGen Announces Further Development Milestone for Use of Its GlymaxX Cancer Cell-killing Enhancement Antibody Technology with Merus N.V.". Berlin....
- [8] Merus N.V.. (2/27/17). "Press Release: Merus to Present at the Cowen & Co. 37th Annual Health Care Conference". Utrecht....
- [9] Merus N.V.. (2/9/17). "Press Release: Merus to Present at the Leerink Partners 6th Annual Global Healthcare Conference". Utrecht....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top